Company intelligence / Profile preview

MantiCore Pharmaceuticals

Salt Lake City, Utah, United States

Ownership: Private
Development stage: Other

Overview

MantiCore Pharmaceuticals was a biotechnology company based in Salt Lake City, Utah, focused on the development of novel oncology therapeutics. Founded in 1995 as a spin-off from the University of Utah, the company specialized in the synthesis of complex small molecules and targeted drug delivery systems. Its research primarily centered on triptolide analogs and cobalamin (Vitamin B12) conjugates designed to inhibit the TFIIH complex and treat various forms of cancer. Led by industry veterans Ned Weinshenker and Gerald T. Simmons, MantiCore was a key player in the early Utah life sciences cluster before becoming inactive in the mid-2000s.

Therapeutic areas: Oncology
Modalities: Small molecule
Industry: Biotech

Partnerships

University of Utah

Beyond the preview

Go deeper on MantiCore Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MantiCore Pharmaceuticals.

Explore the full profile